NUS medical school developing Covid-19 vaccine with Monash University
Researchers from the National University of Singapore (NUS) and Monash University in Australia are developing a Covid-19 vaccine that could be ready for clinical trials by the end of next year.
The vaccine, modified from a cancer drug, has undergone animal studies, and researchers are hoping to conduct clinical trials in Singapore and Australia.
Called Clec9A-RBD, it is the third coronavirus vaccine that Singapore is involved in developing.
